Table 2.
Name | Samples | Interactions | Source |
---|---|---|---|
LncRNA–Disease | 804 × 288 | 1454 | LncRNADisease [16], Lnc2Cancer [17] |
LncRNA–LncRNA | 1114 × 1114 | 1,179,256 | LFSCM [80] |
LncRNA–microRNA | 1127 × 277 | 10,198 | StarBase v2.0 [78] |
LncRNA–Gene | 240 × 15,527 | 6186 | LncRNA2Target [72] |
LncRNA–GO | 240 × 6428 | 3094 | GeneRIF [81] |
MicroRNA–MicroRNA | 271 × 271 | 24,062 | Zhong et al. [82] |
MicroRNA–Disease | 1080 × 592 | 11,835 | HMDD [83], miR2Disease [84], miRCancer [85] |
MicroRNA–Gene | 495 × 15,527 | 135,852 | miRTarBase [86] |
MicroRNA–Target | 495 × 15,527 | 135,852 | miRTarBase [86] |
Gene–Gene | 16,785 × 16,785 | 1,515,370 | Yao et al. [49] |
Gene–Metabolite | 12,342 × 3278 | 192,763 | Yao et al. [49] |
Metabolite–Metabolite | 3764 × 3764 | 74,667 | Yao et al. [49] |
Gene–GO | 15,527 × 6428 | 1,191,503 | GO Annotation [87] |
Gene–Disease | 1715 × 1886 | 2603 | DisGeNET [88] |
Gene–Drug | 155,275 × 8283 | 3760 | DrugBank [89] |
Metabolite–Disease | 388 × 149 | 664 | HMDB [90] |
Drug–Disease | 15,527 × 412 | 115,317 | CTD [91] |
Drug–Drug | 8283 × 8283 | 453,436 | DrugBank [89] |
Drug–Side-effects | 1430 × 5880 | 140,064 | SIDER [92] |
Disease–Disease | 5080 × 5080 | 20,280,092 | Yao et al. [49] |